Five Prime Thera
(FPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 363,341 | 5,858 | 6,315 | 4,287 | 4,645 |
| Gross Profit | 363,341 | 5,858 | 6,315 | 4,287 | 4,645 |
| Operating Expenses | 29,558 | 29,933 | 17,906 | 15,431 | 16,539 |
| Operating Income | 333,783 | -24,075 | -11,591 | -11,144 | -11,894 |
| Other Income | 155 | 104 | 117 | 108 | 68 |
| Pre-tax Income | 333,938 | -23,971 | -11,474 | -11,036 | -11,826 |
| Net Income Continuous | 296,128 | -23,971 | -11,474 | -11,036 | -11,826 |
| Net Income | $296,128 | $-23,971 | $-11,474 | $-11,036 | $-11,826 |
| EPS Basic Total Ops | 11.55 | -0.93 | -0.45 | -0.44 | -0.54 |
| EPS Basic Continuous Ops | 11.54 | -0.93 | -0.45 | -0.44 | -0.55 |
| EPS Diluted Total Ops | 11.05 | -0.93 | -0.45 | -0.44 | -0.54 |
| EPS Diluted Continuous Ops | 11.05 | -0.93 | -0.45 | -0.44 | -0.55 |
| EBITDA(a) | $334,720 | $-23,174 | $-10,660 | $-10,210 | $-11,080 |